Cargando…
Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial
PURPOSE: Many patients develop severe and persistent pain after hepatectomy delaying postoperative rehabilitation. Studies have suggested that intravenous lidocaine infusion relieved postoperative pain and improved overall postoperative outcomes. However, its efficacy on hepatectomy is still masked,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646227/ https://www.ncbi.nlm.nih.gov/pubmed/34880671 http://dx.doi.org/10.2147/JPR.S341550 |
_version_ | 1784610479436464128 |
---|---|
author | Xu, Yan Ye, Mao Hong, Ying Kang, Yi Li, Yue Xiao, Xiao Zhou, Li Jiang, Chunling |
author_facet | Xu, Yan Ye, Mao Hong, Ying Kang, Yi Li, Yue Xiao, Xiao Zhou, Li Jiang, Chunling |
author_sort | Xu, Yan |
collection | PubMed |
description | PURPOSE: Many patients develop severe and persistent pain after hepatectomy delaying postoperative rehabilitation. Studies have suggested that intravenous lidocaine infusion relieved postoperative pain and improved overall postoperative outcomes. However, its efficacy on hepatectomy is still masked, due to the postoperative metabolic change of lidocaine by the liver. We hypothesized that intravenous lidocaine infusion in the perioperative period would lead to postoperative pain reduction and improve the overall patient experience. STUDY DESIGN AND METHODS: In this prospective double-blind, randomized controlled design trial, 260 adults scheduled for hepatectomy will be allocated to the lidocaine and the placebo groups. The lidocaine group will be administered lidocaine intravenously during intraoperative period and 72 postoperative hours; the placebo group will be administered normal saline at the same volume, infusion rate, and timing. The primary outcome is the incidence of moderate-severe pain (numeric rating scale ≥4) during movement at 24 hours after surgery. The secondary outcomes include the incidence of moderate-severe pain at 24 hours after surgery at rest, the incidence of moderate-severe pain at 48 and 72 hours after surgery at rest and during movement, the cumulative morphine consumption at 24, 48 and 72 hours postoperatively, bowel function recovery, the incidence of postoperative nausea and vomiting, the incidence of postoperative pulmonary complications, the length of hospital stay, levels of inflammatory factors and patient satisfaction scores. DISCUSSION: This is the first prospective trial to shed light on the efficacy of intraoperative period and 72 postoperative hours intravenous lidocaine on postoperative pain and recovery after hepatectomy. The findings will provide a new strategy of perioperative pain management for hepatectomy. |
format | Online Article Text |
id | pubmed-8646227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-86462272021-12-07 Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial Xu, Yan Ye, Mao Hong, Ying Kang, Yi Li, Yue Xiao, Xiao Zhou, Li Jiang, Chunling J Pain Res Study Protocol PURPOSE: Many patients develop severe and persistent pain after hepatectomy delaying postoperative rehabilitation. Studies have suggested that intravenous lidocaine infusion relieved postoperative pain and improved overall postoperative outcomes. However, its efficacy on hepatectomy is still masked, due to the postoperative metabolic change of lidocaine by the liver. We hypothesized that intravenous lidocaine infusion in the perioperative period would lead to postoperative pain reduction and improve the overall patient experience. STUDY DESIGN AND METHODS: In this prospective double-blind, randomized controlled design trial, 260 adults scheduled for hepatectomy will be allocated to the lidocaine and the placebo groups. The lidocaine group will be administered lidocaine intravenously during intraoperative period and 72 postoperative hours; the placebo group will be administered normal saline at the same volume, infusion rate, and timing. The primary outcome is the incidence of moderate-severe pain (numeric rating scale ≥4) during movement at 24 hours after surgery. The secondary outcomes include the incidence of moderate-severe pain at 24 hours after surgery at rest, the incidence of moderate-severe pain at 48 and 72 hours after surgery at rest and during movement, the cumulative morphine consumption at 24, 48 and 72 hours postoperatively, bowel function recovery, the incidence of postoperative nausea and vomiting, the incidence of postoperative pulmonary complications, the length of hospital stay, levels of inflammatory factors and patient satisfaction scores. DISCUSSION: This is the first prospective trial to shed light on the efficacy of intraoperative period and 72 postoperative hours intravenous lidocaine on postoperative pain and recovery after hepatectomy. The findings will provide a new strategy of perioperative pain management for hepatectomy. Dove 2021-12-01 /pmc/articles/PMC8646227/ /pubmed/34880671 http://dx.doi.org/10.2147/JPR.S341550 Text en © 2021 Xu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Study Protocol Xu, Yan Ye, Mao Hong, Ying Kang, Yi Li, Yue Xiao, Xiao Zhou, Li Jiang, Chunling Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial |
title | Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial |
title_full | Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial |
title_fullStr | Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial |
title_full_unstemmed | Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial |
title_short | Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial |
title_sort | efficacy of perioperative continuous intravenous lidocaine infusion for 72 hours on postoperative pain and recovery in patients undergoing hepatectomy: study protocol for a prospective randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646227/ https://www.ncbi.nlm.nih.gov/pubmed/34880671 http://dx.doi.org/10.2147/JPR.S341550 |
work_keys_str_mv | AT xuyan efficacyofperioperativecontinuousintravenouslidocaineinfusionfor72hoursonpostoperativepainandrecoveryinpatientsundergoinghepatectomystudyprotocolforaprospectiverandomizedcontrolledtrial AT yemao efficacyofperioperativecontinuousintravenouslidocaineinfusionfor72hoursonpostoperativepainandrecoveryinpatientsundergoinghepatectomystudyprotocolforaprospectiverandomizedcontrolledtrial AT hongying efficacyofperioperativecontinuousintravenouslidocaineinfusionfor72hoursonpostoperativepainandrecoveryinpatientsundergoinghepatectomystudyprotocolforaprospectiverandomizedcontrolledtrial AT kangyi efficacyofperioperativecontinuousintravenouslidocaineinfusionfor72hoursonpostoperativepainandrecoveryinpatientsundergoinghepatectomystudyprotocolforaprospectiverandomizedcontrolledtrial AT liyue efficacyofperioperativecontinuousintravenouslidocaineinfusionfor72hoursonpostoperativepainandrecoveryinpatientsundergoinghepatectomystudyprotocolforaprospectiverandomizedcontrolledtrial AT xiaoxiao efficacyofperioperativecontinuousintravenouslidocaineinfusionfor72hoursonpostoperativepainandrecoveryinpatientsundergoinghepatectomystudyprotocolforaprospectiverandomizedcontrolledtrial AT zhouli efficacyofperioperativecontinuousintravenouslidocaineinfusionfor72hoursonpostoperativepainandrecoveryinpatientsundergoinghepatectomystudyprotocolforaprospectiverandomizedcontrolledtrial AT jiangchunling efficacyofperioperativecontinuousintravenouslidocaineinfusionfor72hoursonpostoperativepainandrecoveryinpatientsundergoinghepatectomystudyprotocolforaprospectiverandomizedcontrolledtrial |